Detection of mutations in EGFR in circulating lung-cancer cells - Test2 - elhamkhani - TriplyDB

Detection of mutations in EGFR in circulating lung-cancer cells

Detection of mutations in EGFR in circulating lung-cancer cells

http://www.wikidata.org/entity/Q29615033

about

Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.Micro-NMR for rapid molecular analysis of human tumor samples Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin Fluid biopsy for solid tumors: a patient's companion for lifelong characterization of their disease Circulating tumor cells: approaches to isolation and characterization High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers Circulating tumor cells: finding the needle in the haystack First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection The steady progress of targeted therapies, promising advances for lung cancer Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review Evaluation and consequences of heterogeneity in the circulating tumor cell compartment When Prostate Cancer Circulates in the Bloodstream Sequence of treatment in locally advanced and metastatic renal cell carcinoma Single-cell analyses of circulating tumor cells Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer The distinctive nature of adenocarcinoma of the lung Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions The influence of subclonal resistance mutations on targeted cancer therapy Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancer Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?A Quantitative Perspective on Surface Marker Selection for the Isolation of Functional Tumor Cells Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges Biosensors for the detection of circulating tumour cells.Porous bead-based diagnostic platforms: bridging the gaps in healthcare Circulating tumors cells as biomarkers: progress toward biomarker qualification Tumour heterogeneity and the evolution of polyclonal drug resistance Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design Minimal residual disease and circulating tumor cells in breast cancer Liquid biopsies: genotyping circulating tumor DNA Ovarian cancer biomarker discovery based on genomic approaches Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer The promise of circulating tumor cell analysis in cancer management Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research

P2860

Q24289207-3A15A055-4F0A-4986-81B0-FA8FF549ED9E Q24603587-5602C738-CC73-4DE8-B594-5ACF16EE374A Q24605776-C5DC3AD4-1483-4FC1-8655-19E0D57867FB Q24623374-C0E9EA59-71FE-4EAF-BF22-AA69CC4F2F70 Q24631347-E580A9F2-BD16-4D80-88C3-0F732CD9E5D4 Q24634121-029350B5-1CC8-4550-8C8C-C55F595C5D13 Q24634168-16CACF67-6B07-4380-85F5-3F302966B168 Q24634952-BDD41871-6E01-42AA-9FB1-B6EB953BFA4D Q26471909-E58F1B16-20A7-4815-AE5C-32E73870E634 Q26741204-5ACA8C51-677E-4AF9-9FEF-56D5B8867ED1 Q26744339-B47C53B7-7165-4FC6-A46E-CF981058BFA8 Q26745560-010DA602-2A4A-42E2-89B6-1E4A8ABE4932 Q26746895-E085AA69-D09F-4BB3-9041-281119573E54 Q26752116-EF7B43CB-1098-418A-9317-7BC7C14467CF Q26765357-9EE05641-E22D-4056-8F1C-13DF113B1D6A Q26768470-AD382F1D-D986-493A-A9A9-323A5A8078D5 Q26773653-AC138B05-C0ED-4F4D-B6D1-CA21E2A4668E Q26778816-205D507D-0C95-49A0-8CDA-C31F021DB85F Q26781088-2E19F179-DA58-41CA-8F46-A24902D73899 Q26781159-B9FBD16A-168D-458E-851A-20F2B06ED775 Q26781333-3E40BD14-03ED-4DB4-8870-E0E4DB6AF58B Q26781693-03CE0583-A5FB-464C-9AB1-B66F3CAFC66D Q26781810-C075F4E8-11B4-4E59-818E-CBCE7AB9B172 Q26796208-6C3F5D99-31CF-457D-A502-B7CB947AEBC2 Q26796595-F7AD8C5E-29A6-4A8D-A18F-D9CF991EB94E Q26797232-38639237-5872-4280-AC00-B90C6E92C5D5 Q26801357-6AA41884-39CC-4EB8-BF50-1BF6CF6B963E Q26823978-D0C406F9-1D8E-402F-A5EE-5511D0822400 Q26827228-F8F619D9-CFD7-482D-A8AA-6B65A43D77EB Q26829421-C9221433-6043-47C4-9665-C8923D5A88AC Q26852579-B1A35A45-FA63-4A36-AFD6-661ED9CF818C Q26866803-0BBEA956-2F71-4783-8BA7-F2E95D3BDC49 Q27003440-2D97D4E5-0E83-4241-95B1-DDE1956D38D4 Q27010152-5FDFF393-210B-430A-B7C6-2F96F5202B41 Q27010159-085CEF00-EB2A-4F99-AB67-F612631A697C Q27013687-08E98ABE-15AB-4779-9CA6-EE4B5DF948E2 Q27014117-D538EF4F-B948-43E1-AEFE-897942783D2B Q27021738-18913589-E1AD-4DD0-ACE0-D93DDFDCD48E Q27022113-D49F3D4B-B4DB-438D-ADEF-0C69F9C0F803 Q27024191-A79FF1A2-9893-4AC8-8353-2A88F4249984

P2860

Detection of mutations in EGFR in circulating lung-cancer cells

http://www.wikidata.org/entity/Q29615033

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Detection of mutations in EGFR in circulating lung-cancer cells

@ast

Detection of mutations in EGFR in circulating lung-cancer cells

@en

type

label

Detection of mutations in EGFR in circulating lung-cancer cells

@ast

Detection of mutations in EGFR in circulating lung-cancer cells

@en

prefLabel

Detection of mutations in EGFR in circulating lung-cancer cells

@ast

Detection of mutations in EGFR in circulating lung-cancer cells

@en

P1433

Q29615033-7EEE4F80-27E8-4100-BBBC-10E026C91384

P1476

Q29615033-98847727-7479-4CD3-BA74-F5376F96E78C

P2093

Q29615033-037B56F3-51C0-4AA4-A599-1182AE5D4B64

Q29615033-09414117-14BD-40E6-AB95-2ED312888FA7

Q29615033-2286400B-B967-4079-86E3-135C028CD593

Q29615033-2D1F4487-396F-4034-89F4-638862B7B3AC

Q29615033-40280AED-51BF-404F-9C18-07C3DE57555F

Q29615033-483DEAA4-724B-45D4-BFC0-1B675CD8A9FE

Q29615033-526A3A1A-76D9-49E0-9259-DE119898550D

Q29615033-691F3929-5B81-4A11-905B-05E3BCF0307F

Q29615033-6C184106-600B-4368-A68D-1A15170B0B66

Q29615033-6C3D3127-C4EA-4586-AE52-73497D50500B

P2860

Q29615033-005F5C02-2443-42FB-A23B-6DB4898F8810

Q29615033-04EB0115-2EBA-49D1-AC1F-9EFE6CA4A943

Q29615033-0F2C9EFA-1A5A-4257-8EFE-F647417C77A7

Q29615033-16C85182-8889-4963-B248-2D6D17AEE015

Q29615033-20AFC3E9-B5D7-49EA-8C6F-D58EE16188AF

Q29615033-33F20A7B-6478-4DBC-A87B-E76CB0A2FCB0

Q29615033-3673F0D3-DC7B-4E28-9ADA-745553370469

Q29615033-39CAE63B-5C0C-4380-9285-5F553EFEC47F

Q29615033-3A02467C-9455-41CB-893A-0C3469B25FCD

Q29615033-3B7C6479-1CF2-47D2-B30A-4BFA4BA6198C

P304

Q29615033-4E75AFEB-703E-4DA9-84EF-242DF5730A24

P31

Q29615033-AE00BF85-FA31-435B-9C94-95FCC20DAF11

P3181

Q29615033-43C4F258-44D7-4904-A7AC-7E7472DF5C65

P356

Q29615033-26ABF113-A2D3-431D-BDB8-CD8803DE3950

P407

Q29615033-6EE2633D-789B-46E2-977A-37D267D443F8

P433

Q29615033-5498D612-E73B-491C-88CE-B1A264F2B976

P478

Q29615033-01CE6819-5AA3-4734-B47C-68707063A247

P577

Q29615033-4E77D3F5-128D-4DC4-85BB-BB6CC77E45FF

P5875

Q29615033-36D9636F-6F35-49F7-BAF1-229822BEF48E

P698

Q29615033-4AC9A5ED-37AD-4824-A468-91AE0DC2B530

P932

Q29615033-7DD07E1B-30C7-4FF3-8C66-9F2672EF47D3

P3181

P356

P1433

The New England Journal of Medicine

P1476

Detection of mutations in EGFR in circulating lung-cancer cells

@en

P2093

Bell DW

http://www.w3.org/2001/XMLSchema#string

Brannigan B

http://www.w3.org/2001/XMLSchema#string

Collura CV

http://www.w3.org/2001/XMLSchema#string

Diederichs S

http://www.w3.org/2001/XMLSchema#string

Digumarthy S

http://www.w3.org/2001/XMLSchema#string

Haber DA

http://www.w3.org/2001/XMLSchema#string

Iafrate AJ

http://www.w3.org/2001/XMLSchema#string

Inserra E

http://www.w3.org/2001/XMLSchema#string

Irimia D

http://www.w3.org/2001/XMLSchema#string

Lynch TJ

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Isolation of rare circulating tumour cells in cancer patients by microchip technology

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

P304

366-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

86153

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0800668

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

359

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5255662

http://www.w3.org/2001/XMLSchema#string

P698

18596266

http://www.w3.org/2001/XMLSchema#string

P932

3551471

http://www.w3.org/2001/XMLSchema#string